Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 27 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

11%

3 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

8 recruiting

Enrollment Performance

Analytics

N/A

12(54.5%)

Phase 4

3(13.6%)

Early Phase 1

3(13.6%)

Phase 2

3(13.6%)

Phase 1

1(4.5%)

22Total

N/A(12)

Phase 4(3)

Early Phase 1(3)

Phase 2(3)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (27)

Showing 20 of 27 trials

NCT07384429Phase 4Recruiting

Effects of Lemborexant on Motor-sleep Comorbidity in Parkinson's Disease

Role: collaborator

NCT07434284Early Phase 1Recruiting

Exploratory Clinical Study of cCTL in Combination With Immunotherapy for Advanced Gynecologic Malignancies

Role: collaborator

NCT05850598Not ApplicableCompleted

Effect of rTMS of the Cerebellum on Parkinson's Disease

Role: collaborator

NCT07230431Not ApplicableNot Yet Recruiting

AI-Assisted Bronchoscopy Navigation and Diagnostic System for Severe Pneumonia: A Multicenter Prospective Study

Role: collaborator

NCT07140601Recruiting

Environmental Pollutants and Neurological Disorders

Role: collaborator

NCT07128394Not ApplicableRecruiting

Extra Luteinizing Hormone Improve Embryo Quality in IVF Patients With Low LH During Long GnRH-Agonist Treatment

Role: lead

NCT07093866Phase 2Recruiting

Efficacy and Safety of Disitamab Vedotin Plus Abiraterone for Metastatic Castration-Resistant Prostate Cancer：a Phase II Study

Role: collaborator

NCT06477211Completed

DNA Methylation Biomarkers to Predict Survival After Surgery for Lung Adenocarcinoma

Role: lead

NCT07005791Not Yet Recruiting

AI-Based Ultrasound Prediction Model for Intracranial Pressure and Prognosis in Lung Cancer Patients With Leptomeningeal Metastasis: A Dual-Center Study

Role: collaborator

NCT06571214Phase 4Not Yet Recruiting

Potential Benefit of r-hLH Addition in Patients Aged 35 to 40 Under Ovarian Stimulation Treatment

Role: lead

NCT06431529Early Phase 1Recruiting

A Study of Tumor Neoantigen-specific T Cells in the Treatment of Advanced Solid Tumors

Role: collaborator

NCT06174597Early Phase 1Recruiting

Umbilical Cord Artery-derived Perivascular Stem Cells for the Critical Limb Ischemia Therapy

Role: lead

NCT06005207Not ApplicableUnknown

Vaginal Progesterone Improves Clinical Outcomes of RIF Patients

Role: lead

NCT05788822Not ApplicableUnknown

MVA to Improve the Pregnancy Outcome in Aged Infertility Women With Assisted Reproductive Technology

Role: lead

NCT05722678Unknown

Study and Analysis of Acute Pancreatitis Complicated With COVID-19

Role: collaborator

NCT05585177Not ApplicableUnknown

Growth Hormone to Improve the Clinical Outcome of Assisted Fertility in Young Patients With Decreased Ovarian Reserve

Role: lead

NCT05545592Not ApplicableRecruiting

Reduced Oestrogen Dosage to Improve the Outcome of Frozen-thawed Embryo Transfer

Role: lead

NCT05232019Completed

Association Between Embryo Implantation Rate and Maternal Age

Role: lead

NCT05105724Phase 2Unknown

Autologous Platelet-rich Plasma to Improve Responsiveness and Embryo Quality in Patients With Poor Ovarian Response

Role: lead

NCT04938011Phase 2Unknown

A Randomized Controlled Study of Prolonging the Time of Progesterone Supplementation to Improve the Pregnancy Outcome of Single Day 6 Blastocyst Transfer of Freeze-thaw Cycle

Role: lead